Cutler Group LP Sangamo Therapeutics, Inc Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$2.77 - $5.07 $277 - $507	-100 Reduced 3.85%	2,500 $0
Q3 2022 Oct 25, 2022	SELL	$4.27 - $6.39 $853 - $1,278	-200 Reduced 7.14%	2,600 $0
Q2 2022 Aug 04, 2022	SELL	$3.28 - $6.21 $16,728 - $31,671	-5,100 Reduced 64.56%	2,800 $0
Q1 2022 Apr 14, 2022	SELL	$5.23 - $7.82 $18,828 - $28,152	-3,600 Reduced 31.3%	7,900 $1,000
Q4 2017 Jan 17, 2018	SELL	$11.6 - $17.35 $77,720 - $116,245	-6,700 Reduced 36.81%	11,500 $62,000
Q3 2017 Oct 17, 2017	BUY	$8.4 - $15.0 $152,880 - $273,000	18,200	18,200 $117,000

109

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.